Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2024
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual DiseaseAnne Tierens, Nira Arad-Cohen, Daniel Cheuk, et al.
Epigenetics|August 23, 2014
RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemiaAnna R Poetsch, Daniel B Lipka, Tania Witte, et al.
Haematologica|August 3, 2019
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartmentBarbara Depreter, Karin E Weening, Karl Vandepoele, et al.
Haematologica|July 29, 2017
Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951Veerle Mondelaers, Stefan Suciu, Barbara De Moerloose, et al.
Leukemia|April 26, 2022
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international studyElad Jacoby, Sara Ghorashian, Britta Vormoor, et al.
Haematologica|October 23, 2025
Children with chronic phase chronic myeloid leukemia: characteristics and outcomes from the International Registry of Childhood CMLFrédéric Millot, Joe De Keizer, Markus Metzler, et al.
Blood|March 17, 2011
Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcomeChristiane Olk-Batz, Anna R Poetsch, Peter Nöllke, et al.
Blood|January 13, 2012
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMMLShinsuke Hirabayashi, Christian Flotho, Jessica Moetter, et al.
Expert Review of Anticancer Therapy|October 3, 2022
Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortiumNira Arad-Cohen, Bernward Zeller, Jonas Abrahamsson, et al.
British Journal of Haematology|January 15, 2016
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study groupAnnamaria M Cseh, Charlotte M Niemeyer, Ayami Yoshimi, et al.
Pageof 13